Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin

Leukemia. 1997 Sep;11(9):1594-5. doi: 10.1038/sj.leu.2400747.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Bone Marrow / drug effects
  • Cell Survival / drug effects
  • Child
  • Cytarabine / therapeutic use*
  • Daunorubicin / therapeutic use*
  • Down Syndrome / complications
  • Down Syndrome / pathology*
  • Humans
  • Leukemia, Myeloid / complications
  • Leukemia, Myeloid / drug therapy*
  • Tumor Cells, Cultured / drug effects

Substances

  • Cytarabine
  • Daunorubicin